US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Relmada Therapeutics, Inc.

0.6254

-0.0150-2.34%

Post-market: 0.6250-0.0004-0.06%18:32 EDT

Volume:52.75K

Turnover:32.93K

Market Cap:20.76M

PE:-0.25

High:0.6444

Open:0.6212

Low:0.6043

Close:0.6404

Loading ...

Overview Company News Filings

Relmada Therapeutics Inc. Faces Nasdaq Listing Challenge Due to Sub-$1 Share Price

Relmada Therapeutics appoints Lotan to Chair of Clinical Advisory Board

Press Release: Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology

Relmada Therapeutics (RLMD) Receives a Hold from Mizuho Securities

Relmada Therapeutics Inc. Conducted Annual Stockholders Meeting

Paul Edward Kelly, COO, Reports Acquisition of Relmada Therapeutics Inc. Common Shares

Relmada Therapeutics CFO Maged Shenouda Reports Acquisition of Common Shares

CEO Sergio Traversa Acquires Common Shares of Relmada Therapeutics Inc

Relmada Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Relmada Therapeutics Inc. Switches Audit Firms Amid Acquisition, No Disagreements Reported

BRIEF-Relmada Therapeutics Q1 Net Income USD -17.5 Million

Relmada Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview

Relmada Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview

Relmada Therapeutics Reports 'Positive' Phase 2 Data for Bladder Cancer Treatment

MT Newswires Live

Relmada Therapeutics presents initial Phase 2 NDV-01 data at AUA2025

Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025

Psychedelic: Clearmind completes clinical site initiations for AUD trial

Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data

Relmada Therapeutics To Present NDV-01 Data at AUA2025

Q4 2024 Relmada Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RLMD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RLMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RLMD\",,,,,undefined,":{"symbol":"RLMD","market":"US","secType":"STK","nameCN":"Relmada Therapeutics, Inc.","latestPrice":0.6254,"timestamp":1753819200000,"preClose":0.6404,"halted":0,"volume":52749,"hourTrading":{"tag":"盘后","latestPrice":0.625,"preClose":0.6254,"latestTime":"18:32 EDT","volume":1223,"amount":764.375,"timestamp":1753828366175},"delay":0,"floatShares":24521688,"shares":33191622,"eps":-2.504245,"marketStatus":"Not Yet Opened","change":-0.015,"latestTime":"07-29 16:00:00 EDT","open":0.6212,"high":0.644437,"low":0.6043,"amount":32931.1110267,"amplitude":0.062675,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.504245,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753862400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.6404,"postHourTrading":{"tag":"盘后","latestPrice":0.625,"preClose":0.6254,"latestTime":"18:32 EDT","volume":1223,"amount":764.375,"timestamp":1753828366175},"volumeRatio":0.146104,"impliedVol":2.8827,"impliedVolPercentile":0.968},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RLMD\",,,,,undefined,":{"symbol":"RLMD","floatShares":24521688,"roa":"-88.24%","roe":"-160.26%","lyrEps":-2.651505,"volumeRatio":0.146104,"shares":33191622,"dividePrice":0,"high":0.644437,"amplitude":0.062675,"preClose":0.6404,"low":0.6043,"week52Low":0.2404,"pbRate":"0.93","week52High":4.015,"institutionHeld":0,"latestPrice":0.6254,"eps":-2.504245,"divideRate":0,"volume":52749,"delay":0,"ttmEps":-2.504245,"open":0.6212,"prevYearClose":0.52,"prevWeekClose":0.6467,"prevMonthClose":0.6003,"prevQuarterClose":0.6003,"fiveDayClose":0.6255,"twentyDayClose":0.6003,"sixtyDayClose":0.3497},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RLMD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553122815","title":"Relmada Therapeutics Inc. Faces Nasdaq Listing Challenge Due to Sub-$1 Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2553122815","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553122815?lang=en_us&edition=fundamental","pubTime":"2025-07-24 04:31","pubTimestamp":1753302685,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc. has announced a regulatory issue regarding its listing on the Nasdaq Stock Market. The company received notice from Nasdaq that it failed to maintain a minimum bid price of $1 per share for 30 consecutive business days, as required by Nasdaq's listing rules. On July 22, 2025, Nasdaq approved the transfer of Relmada's listing to the Nasdaq Capital Market and granted an extension until January 19, 2026, to regain compliance. To meet the requirements, Relmada's stock must have a closing bid price of at least $1 for ten consecutive business days within the compliance period. The company is actively monitoring the situation and exploring measures to maintain its Nasdaq listing. However, there is no guarantee that compliance will be achieved.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nNDL5DxrGV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2551268162","title":"Relmada Therapeutics appoints Lotan to Chair of Clinical Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2551268162","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551268162?lang=en_us&edition=fundamental","pubTime":"2025-07-15 20:28","pubTimestamp":1752582526,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics (RLMD) announced the appointment of Yair Lotan, MD, a distinguished urologic oncologist, as Chair of Relmada’s Clinical Adviso...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/relmada-therapeutics-appoints-lotan-to-chair-of-clinical-advisory-board-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/relmada-therapeutics-appoints-lotan-to-chair-of-clinical-advisory-board-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","RLMD","BK4539","BK4139"],"gpt_icon":0},{"id":"2544692419","title":"Press Release: Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology","url":"https://stock-news.laohu8.com/highlight/detail?id=2544692419","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544692419?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:00","pubTimestamp":1750158000,"startTime":"0","endTime":"0","summary":"Dr. Pruthi brings vast clinical development experience advancing novel therapies for NMIBC. \"We are very pleased to welcome Raj to Relmada. As we prepare to begin registrational studies, we believe Raj's extensive clinical experience will play a vital role in the NDV-01 program's success,\" said Sergio Traversa, Chief Executive Officer, Relmada. \"Additionally, we have a strong belief that Raj's first-hand understanding of approved bladder cancer therapies and the clinical evidence that is required for widespread physician adoption of new therapies will be a significant asset for Relmada.\". Raj Pruthi is an accomplished physician, surgeon and clinical scientist with an extensive career in academic medicine and industry and long publication history. Prior to joining Relmada, Dr. Pruthi was Chief Medical Officer at en","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4007","RLMD","MD","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2542656568","title":"Relmada Therapeutics (RLMD) Receives a Hold from Mizuho Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2542656568","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542656568?lang=en_us&edition=fundamental","pubTime":"2025-06-12 10:55","pubTimestamp":1749696914,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Uy Ear maintained a Hold rating on Relmada Therapeutics (RLMD – Research Report) yesterday and set a price target of $1.0...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/relmada-therapeutics-rlmd-receives-a-hold-from-mizuho-securities-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/relmada-therapeutics-rlmd-receives-a-hold-from-mizuho-securities-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFG","RLMD","BK4207","BK4007"],"gpt_icon":0},{"id":"2538491709","title":"Relmada Therapeutics Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2538491709","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538491709?lang=en_us&edition=fundamental","pubTime":"2025-05-28 04:15","pubTimestamp":1748376958,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc. held its 2025 Annual Meeting of Stockholders on May 23, 2025. During the meeting, stockholders elected John Glasspool as a Class I Director. The appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. An amendment to the 2021 Equity Incentive Plan, increasing the number of shares available for issuance by 2,000,000, was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relmada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2025, and is solely r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nNDL2p8KTQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2537629883","title":"Paul Edward Kelly, COO, Reports Acquisition of Relmada Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2537629883","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537629883?lang=en_us&edition=fundamental","pubTime":"2025-05-21 06:04","pubTimestamp":1747778662,"startTime":"0","endTime":"0","summary":"Paul Edward Kelly, Chief Operating Officer and Director, reported an acquisition of common shares of Relmada Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relmada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL4NCgDr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2537626058","title":"Relmada Therapeutics CFO Maged Shenouda Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2537626058","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537626058?lang=en_us&edition=fundamental","pubTime":"2025-05-21 06:03","pubTimestamp":1747778623,"startTime":"0","endTime":"0","summary":"Maged Shenouda, the Chief Financial Officer of Relmada Therapeutics Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relmada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL7bGlCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2537626054","title":"CEO Sergio Traversa Acquires Common Shares of Relmada Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2537626054","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537626054?lang=en_us&edition=fundamental","pubTime":"2025-05-21 06:02","pubTimestamp":1747778535,"startTime":"0","endTime":"0","summary":"Sergio Traversa, Chief Executive Officer of Relmada Therapeutics Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relmada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL3MX6HC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2535787382","title":"Relmada Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535787382","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535787382?lang=en_us&edition=fundamental","pubTime":"2025-05-13 05:00","pubTimestamp":1747083657,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryRelmada Therapeutics Inc RLMD.OQ reported a quarterly adjusted loss of 58 cents per share for the quarter ende","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nL8N3RK2PL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD"],"gpt_icon":0},{"id":"2535789769","title":"Relmada Therapeutics Inc. Switches Audit Firms Amid Acquisition, No Disagreements Reported","url":"https://stock-news.laohu8.com/highlight/detail?id=2535789769","media":"Reuters","labels":["merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535789769?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:07","pubTimestamp":1747080430,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc. has announced a change in its certifying accountants following the acquisition of Marcum LLP's attest business by CBIZ CPAs P.C. As a result of this acquisition, Relmada has dismissed Marcum as its independent registered public accounting firm, effective May 8, 2025, with the approval of the company's audit committee. Marcum's audit reports for fiscal years 2023 and 2024 did not contain adverse or qualified opinions, except for an explanatory note on the company's ability to continue as a going concern. Subsequently, CBIZ CPAs has been engaged as the new independent registered public accounting firm for the fiscal year ending December 31, 2025. The company noted that during the fiscal years 2023 and 2024, there were no disagreements or reportable events with Marcum concerning accounting principles, practices, or financial disclosures.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nNDL8THyyQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBZ","RLMD","BK4123","BK4007","LU2065732104.USD"],"gpt_icon":0},{"id":"2535178953","title":"BRIEF-Relmada Therapeutics Q1 Net Income USD -17.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535178953","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535178953?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:01","pubTimestamp":1747080106,"startTime":"0","endTime":"0","summary":"BRIEF-Relmada Therapeutics Q1 Net Income USD -17.5 Million\n\n\nMay 12 (Reuters) - Relmada Therapeutics Q1 cash & investments USD 27.1 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nPLXFED7FF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2534461650","title":"Relmada Therapeutics Inc  expected to post a loss of 31 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534461650","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534461650?lang=en_us&edition=fundamental","pubTime":"2025-05-10 06:29","pubTimestamp":1746829747,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc  expected to post a loss of31cents a share - Earnings Preview Relmada Therapeutics Inc RLMD.OQ RLMD.O is expected to show no change in quarterly revenue when it reports  resul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH3N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD"],"gpt_icon":0},{"id":"2532817166","title":"Relmada Therapeutics Inc  expected to post a loss of 31 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2532817166","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532817166?lang=en_us&edition=fundamental","pubTime":"2025-05-02 19:26","pubTimestamp":1746185179,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc  expected to post a loss of31cents a share - Earnings Preview Relmada Therapeutics Inc RLMD.OQ RLMD.O is expected to show no change in quarterly revenue when it reports  resul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nL8N3RA1CB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD"],"gpt_icon":0},{"id":"2531944254","title":"Relmada Therapeutics Reports 'Positive' Phase 2 Data for Bladder Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2531944254","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531944254?lang=en_us&edition=fundamental","pubTime":"2025-04-29 03:03","pubTimestamp":1745867006,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics  said Friday initial results from a phase 2 trial of NDV-01 for bladder cancer were positive.The study, which was presented at the annual meeting of the American Urology Association, showed that 90% of patients achieved high-grade disease-free status after treatment, supporting NDV-01's potential as a new therapy for non-muscle invasive bladder cancer, the company said.At the three-month mark, 85% of patients responded to treatment, and all patients with carcinoma in situ showed a complete response, it added.At six months, all seven patients who were evaluated remained disease-free, including one who needed a second treatment at three months, according to the company.The drug was generally safe and well-tolerated, with only mild side effects like urinary urgency and slight pain, which resolved within a day, Relmada said.Shares of the company were down over 41% in recent trading.Price: 0.38, Change: -0.27, Percent Change: -41.30","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LENZ","RLMD","BK4139"],"gpt_icon":0},{"id":"2531568922","title":"Relmada Therapeutics presents initial Phase 2 NDV-01 data at AUA2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531568922","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531568922?lang=en_us&edition=fundamental","pubTime":"2025-04-29 01:46","pubTimestamp":1745862373,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics (RLMD) announced that “positive” initial data from the Phase 2 study of NDV-01 showed that 90% of patients achieved high-grade...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/relmada-therapeutics-presents-initial-phase-2-ndv-01-data-at-aua2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/relmada-therapeutics-presents-initial-phase-2-ndv-01-data-at-aua2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RLMD","LENZ","BK4007"],"gpt_icon":0},{"id":"2531558002","title":"Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531558002","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531558002?lang=en_us&edition=fundamental","pubTime":"2025-04-29 01:38","pubTimestamp":1745861880,"startTime":"0","endTime":"0","summary":"90% of patients achieved high grade disease-free status at any time point with NDV-01, demonstrating strong proof-of-concept for sustained-release “GEM/DOCE” formulation*. NDV-01 showed promising clinical activity in BCG-nave and BCG-unresponsive patients, with favorable overall tolerability. Data to be reviewed at Investor Event on April 28, 2025 at 4:30 PM ET. CORAL GABLES, Fla., April 28, 2025  -- Relmada Therapeutics, Inc. , a clinical-stage biotechnology company, today announced that positive initial data from the Phase 2 study of NDV-01 showed that 90% of patients achieved high-grade disease-free status at any time point following treatment, demonstrating strong clinical activity and supporting further development of NDV-01 for the treatment of non-muscle invasive bladder cancer . The data were presented today at the American Urology Association 2025  Annual Meeting with a data cutoff date of April 20, 2025. To register for the virtual Investor Event, click here.Overall: The trea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/relmada-therapeutics-presents-positive-initial-173800225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ORR","BK4139","CR","BK4007","LENZ","BK4161","RLMD"],"gpt_icon":0},{"id":"2530215933","title":"Psychedelic: Clearmind completes clinical site initiations for AUD trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2530215933","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530215933?lang=en_us&edition=fundamental","pubTime":"2025-04-25 23:30","pubTimestamp":1745595026,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on site initiations, dosing completion and clinical site partnerships.Discover outperforming stocks and invest smarter with Top Smart Score Stocks.Filter, analyze, and streamline your search for investment opportunities using  Tipranks' Stock Screener.“AUD remains one of the most urgent and underserved public health challenges globally,” said Dr. Adi Zuloff-Shani, CEO. “With millions affected and current treatments often falling short, the study initiation for our FDA-approved CMND-100 trial marks a critical step toward potentially transforming the treatment landscape for alcoholism. We are honored to collaborate with world renowned institutions such as Yale and Johns Hopkins as we advance our mission to potentially provide safe, effective, and innovative solutions for individuals those suffering from alcoholism.”“Completing dosing of all participants in Part A of our 005 tria","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MDXXF","QNTM","PBM","CMND","BK4547","ENVB","CMPS","NRXP","DRUG","KTTA","PHRRF","PSYGF","SEEL","ENTBF","ATAI","SILO","BK4168","BK4139","MNMD","IXHL","RVVTF","GHRS","OPTHF","AGNPF","SNPX","ALID","RLMD","BETRF","BK4202","BK4539","CYBN","MIRA","FLHLF","MYCOF","SPRC","BK4007","NUMIF"],"gpt_icon":0},{"id":"2530501469","title":"Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2530501469","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530501469?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:00","pubTimestamp":1745496000,"startTime":"0","endTime":"0","summary":"April 28th AUA data presentation to highlight study in patients with high-gradenon-muscle invasive bladder cancer . Virtual event to be held on April 28, 2025 at 4:30 PM ET. CORAL GABLES, Fla., April 24, 2025  -- Relmada Therapeutics, Inc. , a clinical-stage biotechnology company, today announced it will host a virtual key opinion leader  event on Monday, April 28, 2025 at 4:30 PM ET. To register, please click here.The event will feature Boris Chertin, MD  and Yair Lotan, MD , who will join Relmada’s management to discuss topline efficacy and safety data from the Phase 2 study evaluating NDV-01 for the treatment of high-grade non-muscle invasive bladder cancer . The data will be presented at the American Urological Association meeting , on April 28, 2025 in Las Vegas, Nevada.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/relmada-therapeutics-host-kol-event-120000022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","HST","BK4585","KOL","LENZ","BK4588","BK4181","BK4007","RLMD","BK4218"],"gpt_icon":0},{"id":"2527159483","title":"Relmada Therapeutics To Present NDV-01 Data at AUA2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2527159483","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527159483?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:30","pubTimestamp":1744630200,"startTime":"0","endTime":"0","summary":"CORAL GABLES, Fla., April 14, 2025  -- Relmada Therapeutics, Inc. , a clinical-stage biotechnology company, today announced the presentation of an abstract at the American Urology Association , taking place from April 26-29th in Las Vegas.Prospective Open Label Study to Evaluate the Safety and Efficacy of Safety and Efficacy of intravesical sustained release Gemcitabine Docetaxel combination  in High Risk NMIBC: P2 on Apr 25. About NDV-01NDV-01 is an investigational, innovative sustained-release formulation of two complementary, well-established, chemotherapy agents, gemcitabine and docetaxel . It is designed for intravesical dosing and intended to be an in-office ready-to-use therapy that is administered rapidly and requires no anesthesia or new or dedicated equipment to employ. NDV-01 forms a spherical soft matrix within the bladder that sequesters drug and releases it as the matrix gradually dissolves.NDV-01 is protected by several patents that go out to 2038.The U.S. NMIBC market i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/relmada-therapeutics-present-ndv-01-113000967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","RLMD","BK4007","LENZ"],"gpt_icon":0},{"id":"2522679522","title":"Q4 2024 Relmada Therapeutics Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2522679522","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522679522?lang=en_us&edition=fundamental","pubTime":"2025-03-28 19:05","pubTimestamp":1743159928,"startTime":"0","endTime":"0","summary":"Brian Ritchie; Managing Director, LifeSci Advisors, LLC; Relmada Therapeutics Inc. Sergio Traversa; Chief Executive Officer, Director; Relmada Therapeutics Inc. Maged Shenouda; Chief Financial Officer; Relmada Therapeutics Inc. Greetings and welcome to the Relmada Therapeutics Incorporated quarter four 2024 financial results call.It is now my pleasure to introduce Brian Ritchie.Thank you. Brian, you may be good.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-relmada-therapeutics-inc-110528479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RLMD","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":34,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RLMD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"RLMD","fiscalQuarterEnding":"2025/03","expectedEps":-0.31,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2025-03-27","symbol":"RLMD","fiscalQuarterEnding":"2024/12","expectedEps":-0.7,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.62},{"market":"US","date":"2024-11-07","symbol":"RLMD","fiscalQuarterEnding":"2024/09","expectedEps":-0.65,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.72},{"market":"US","date":"2024-08-07","symbol":"RLMD","fiscalQuarterEnding":"2024/06","expectedEps":-0.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.59},{"market":"US","date":"2024-05-08","symbol":"RLMD","fiscalQuarterEnding":"2024/03","expectedEps":-0.9,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.72}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RLMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RLMD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":2,"updateTime":1733371200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RLMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RLMD","date":"2025-07-28","current":-0.283514,"percent":0.891217,"low":-25.805609,"twenty":-6.9959,"median":-1.307396,"eighty":-0.59771,"high":-0.088966,"avg":-4.421086,"sd":5.469141,"marketCap":21465021},"quantilePoints":[{"date":"2020-07-31","current":-24.040727,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":552755224},{"date":"2020-08-07","current":-23.743276,"twenty":-5.700374,"median":-1.733041,"eighty":-0.357515,"marketCap":545916075},{"date":"2020-08-14","current":-19.888133,"twenty":-5.712286,"median":-1.733041,"eighty":-0.357515,"marketCap":596411270},{"date":"2020-08-21","current":-20.876662,"twenty":-5.737576,"median":-1.733041,"eighty":-0.357515,"marketCap":626055570},{"date":"2020-08-28","current":-18.637777,"twenty":-5.855718,"median":-1.733041,"eighty":-0.357515,"marketCap":558915236},{"date":"2020-09-04","current":-19.610276,"twenty":-5.948456,"median":-1.733041,"eighty":-0.357515,"marketCap":588078818},{"date":"2020-09-11","current":-19.36448,"twenty":-6.126741,"median":-1.733041,"eighty":-0.357515,"marketCap":580707803},{"date":"2020-09-18","current":-21.469779,"twenty":-6.279615,"median":-1.733041,"eighty":-0.357515,"marketCap":643842150},{"date":"2020-09-25","current":-19.66371,"twenty":-6.401962,"median":-1.733041,"eighty":-0.357515,"marketCap":589681212},{"date":"2020-10-02","current":-20.956813,"twenty":-6.49254,"median":-1.758166,"eighty":-0.357515,"marketCap":628459162},{"date":"2020-10-09","current":-20.860631,"twenty":-6.752577,"median":-1.818793,"eighty":-0.357515,"marketCap":625574851},{"date":"2020-10-16","current":-18.62709,"twenty":-13.145747,"median":-1.818793,"eighty":-0.357515,"marketCap":558594757},{"date":"2020-10-23","current":-17.814894,"twenty":-14.590145,"median":-1.853436,"eighty":-0.357515,"marketCap":534238359},{"date":"2020-10-30","current":-16.527134,"twenty":-14.890092,"median":-1.884167,"eighty":-0.357515,"marketCap":495620649},{"date":"2020-11-06","current":-17.040101,"twenty":-15.202709,"median":-1.905402,"eighty":-0.357515,"marketCap":511003637},{"date":"2020-11-13","current":-12.23902,"twenty":-15.348585,"median":-1.975556,"eighty":-0.357515,"marketCap":528986501},{"date":"2020-11-20","current":-13.854856,"twenty":-15.348585,"median":-2.000672,"eighty":-0.357515,"marketCap":598825063},{"date":"2020-11-27","current":-13.524173,"twenty":-15.348585,"median":-2.052637,"eighty":-0.357515,"marketCap":584532520},{"date":"2020-12-04","current":-13.152155,"twenty":-15.348585,"median":-2.07862,"eighty":-0.357515,"marketCap":568453410},{"date":"2020-12-11","current":-12.344237,"twenty":-15.348585,"median":-2.07862,"eighty":-0.357515,"marketCap":533534129},{"date":"2020-12-18","current":-12.663647,"twenty":-15.348585,"median":-2.160184,"eighty":-0.357515,"marketCap":547339426},{"date":"2020-12-24","current":-12.069921,"twenty":-15.348585,"median":-2.191878,"eighty":-0.357515,"marketCap":521677815},{"date":"2020-12-31","current":-12.051132,"twenty":-15.348585,"median":-2.251839,"eighty":-0.357515,"marketCap":520865738},{"date":"2021-01-08","current":-13.309981,"twenty":-15.348585,"median":-2.315052,"eighty":-0.357515,"marketCap":575274850},{"date":"2021-01-15","current":-13.854856,"twenty":-15.348585,"median":-2.359402,"eighty":-0.357515,"marketCap":598825063},{"date":"2021-01-22","current":-13.426472,"twenty":-15.348585,"median":-2.390413,"eighty":-0.361852,"marketCap":580309723},{"date":"2021-01-29","current":-12.280355,"twenty":-15.348585,"median":-2.511008,"eighty":-0.36481,"marketCap":530773069},{"date":"2021-02-05","current":-12.716255,"twenty":-15.348585,"median":-2.576427,"eighty":-0.370059,"marketCap":549613239},{"date":"2021-02-12","current":-13.704546,"twenty":-15.348585,"median":-2.617786,"eighty":-0.372159,"marketCap":592328453},{"date":"2021-02-19","current":-14.035229,"twenty":-15.348585,"median":-2.645672,"eighty":-0.372159,"marketCap":606620996},{"date":"2021-02-26","current":-12.528367,"twenty":-15.348585,"median":-2.728189,"eighty":-0.372159,"marketCap":541492476},{"date":"2021-03-05","current":-12.862808,"twenty":-15.354462,"median":-2.841532,"eighty":-0.371634,"marketCap":555947434},{"date":"2021-03-12","current":-13.779701,"twenty":-15.354462,"median":-2.841532,"eighty":-0.391734,"marketCap":595576758},{"date":"2021-03-19","current":-13.742123,"twenty":-15.354462,"median":-2.877762,"eighty":-0.424703,"marketCap":593952605},{"date":"2021-03-26","current":-9.271938,"twenty":-15.348585,"median":-2.890274,"eighty":-0.43007,"marketCap":551276015},{"date":"2021-04-01","current":-10.323333,"twenty":-15.348585,"median":-2.926862,"eighty":-0.438333,"marketCap":613788141},{"date":"2021-04-09","current":-9.923356,"twenty":-15.354462,"median":-2.987177,"eighty":-0.437014,"marketCap":590006991},{"date":"2021-04-16","current":-9.771253,"twenty":-15.354462,"median":-3.013299,"eighty":-0.437014,"marketCap":580963455},{"date":"2021-04-23","current":-10.376851,"twenty":-15.354462,"median":-3.039204,"eighty":-0.437014,"marketCap":616970126},{"date":"2021-04-30","current":-10.861329,"twenty":-15.354462,"median":-3.077954,"eighty":-0.437014,"marketCap":645775463},{"date":"2021-05-07","current":-10.236014,"twenty":-15.354462,"median":-3.096464,"eighty":-0.437014,"marketCap":608596482},{"date":"2021-05-14","current":-8.003248,"twenty":-15.354462,"median":-3.13772,"eighty":-0.437014,"marketCap":568216697},{"date":"2021-05-21","current":-8.968464,"twenty":-15.354462,"median":-3.169112,"eighty":-0.437014,"marketCap":636745344},{"date":"2021-05-28","current":-8.183043,"twenty":-15.354462,"median":-3.187536,"eighty":-0.437014,"marketCap":580981837},{"date":"2021-06-04","current":-7.12793,"twenty":-15.354462,"median":-3.192703,"eighty":-0.437014,"marketCap":506070620},{"date":"2021-06-11","current":-7.366868,"twenty":-15.354462,"median":-3.196717,"eighty":-0.437014,"marketCap":523034820},{"date":"2021-06-18","current":-7.310091,"twenty":-15.354462,"median":-3.215186,"eighty":-0.437014,"marketCap":519003723},{"date":"2021-06-25","current":-8.126266,"twenty":-15.354462,"median":-3.245915,"eighty":-0.437014,"marketCap":576950740},{"date":"2021-07-02","current":-7.71463,"twenty":-15.354462,"median":-3.278609,"eighty":-0.437014,"marketCap":547725288},{"date":"2021-07-09","current":-8.097877,"twenty":-15.354462,"median":-3.296823,"eighty":-0.437014,"marketCap":574935192},{"date":"2021-07-16","current":-7.373965,"twenty":-15.354462,"median":-3.315038,"eighty":-0.443169,"marketCap":523538707},{"date":"2021-07-23","current":-6.127228,"twenty":-15.354462,"median":-3.370574,"eighty":-0.443169,"marketCap":435022538},{"date":"2021-07-30","current":-6.150886,"twenty":-15.354462,"median":-3.371104,"eighty":-0.555367,"marketCap":436702162},{"date":"2021-08-06","current":-5.568917,"twenty":-15.354462,"median":-3.380611,"eighty":-0.578507,"marketCap":395383418},{"date":"2021-08-13","current":-4.61934,"twenty":-15.354462,"median":-3.397035,"eighty":-0.605119,"marketCap":399257730},{"date":"2021-08-20","current":-4.534433,"twenty":-15.354462,"median":-3.424324,"eighty":-0.659499,"marketCap":391919075},{"date":"2021-08-27","current":-4.890234,"twenty":-15.354462,"median":-3.448899,"eighty":-0.746275,"marketCap":422671531},{"date":"2021-09-03","current":-4.932687,"twenty":-15.354462,"median":-3.460753,"eighty":-0.821481,"marketCap":426340858},{"date":"2021-09-10","current":-5.260185,"twenty":-15.354462,"median":-3.485622,"eighty":-0.850406,"marketCap":454647095},{"date":"2021-09-17","current":-5.571511,"twenty":-15.354462,"median":-3.500762,"eighty":-0.850406,"marketCap":481555494},{"date":"2021-09-24","current":-5.882836,"twenty":-15.354462,"median":-3.51567,"eighty":-0.850406,"marketCap":508463892},{"date":"2021-10-01","current":-5.40574,"twenty":-15.354462,"median":-3.578556,"eighty":-0.970791,"marketCap":467227645},{"date":"2021-10-08","current":-5.290509,"twenty":-15.354462,"median":-3.584692,"eighty":-1.000536,"marketCap":457268043},{"date":"2021-10-15","current":-4.777025,"twenty":-15.354462,"median":-3.605816,"eighty":-1.014057,"marketCap":412886659},{"date":"2021-10-22","current":-4.815435,"twenty":-15.354462,"median":-3.628468,"eighty":-1.022224,"marketCap":416206526},{"date":"2021-10-29","current":-4.744679,"twenty":-15.354462,"median":-3.668784,"eighty":-1.054619,"marketCap":410090981},{"date":"2021-11-05","current":-5.314768,"twenty":-15.354462,"median":-3.690124,"eighty":-1.081661,"marketCap":459364801},{"date":"2021-11-12","current":-3.567592,"twenty":-15.354462,"median":-3.789733,"eighty":-1.415629,"marketCap":400053540},{"date":"2021-11-19","current":-3.187695,"twenty":-15.354462,"median":-3.789733,"eighty":-1.448079,"marketCap":357453623},{"date":"2021-11-26","current":-2.943811,"twenty":-15.354462,"median":-3.789733,"eighty":-1.458021,"marketCap":330105528},{"date":"2021-12-03","current":-2.646772,"twenty":-15.354462,"median":-3.789733,"eighty":-1.458229,"marketCap":296796951},{"date":"2021-12-10","current":-4.42415,"twenty":-15.354462,"median":-3.795557,"eighty":-1.477343,"marketCap":496104008},{"date":"2021-12-17","current":-4.705268,"twenty":-15.354462,"median":-3.795557,"eighty":-1.499231,"marketCap":527627378},{"date":"2021-12-23","current":-5.501431,"twenty":-15.354462,"median":-3.909674,"eighty":-1.532958,"marketCap":616905369},{"date":"2021-12-31","current":-5.570662,"twenty":-15.354462,"median":-4.004888,"eighty":-1.552453,"marketCap":624668672},{"date":"2022-01-07","current":-5.170108,"twenty":-15.348585,"median":-4.217285,"eighty":-1.558965,"marketCap":579752416},{"date":"2022-01-14","current":-4.91049,"twenty":-15.348585,"median":-4.421677,"eighty":-1.560442,"marketCap":550640028},{"date":"2022-01-21","current":-4.591531,"twenty":-15.348585,"median":-4.551617,"eighty":-1.56326,"marketCap":514873379},{"date":"2022-01-28","current":-4.32944,"twenty":-15.348585,"median":-4.580166,"eighty":-1.579649,"marketCap":485483730},{"date":"2022-02-04","current":-4.195923,"twenty":-15.348585,"median":-4.580166,"eighty":-1.584662,"marketCap":470511645},{"date":"2022-02-11","current":-4.569278,"twenty":-15.348585,"median":-4.605436,"eighty":-1.606919,"marketCap":512378032},{"date":"2022-02-18","current":-4.517354,"twenty":-15.348585,"median":-4.634752,"eighty":-1.627238,"marketCap":506555554},{"date":"2022-02-25","current":-5.081097,"twenty":-15.348585,"median":-4.649032,"eighty":-1.637901,"marketCap":569771026},{"date":"2022-03-04","current":-5.093459,"twenty":-15.348585,"median":-4.686724,"eighty":-1.645574,"marketCap":571157330},{"date":"2022-03-11","current":-5.498958,"twenty":-15.348585,"median":-4.748722,"eighty":-1.671902,"marketCap":616628108},{"date":"2022-03-18","current":-5.953908,"twenty":-15.348585,"median":-4.779046,"eighty":-1.671902,"marketCap":667644102},{"date":"2022-03-25","current":-6.013944,"twenty":-15.348585,"median":-4.795535,"eighty":-1.724543,"marketCap":756264367},{"date":"2022-04-01","current":-6.866406,"twenty":-15.348585,"median":-4.819018,"eighty":-1.749505,"marketCap":863463006},{"date":"2022-04-08","current":-6.209434,"twenty":-15.348585,"median":-4.84677,"eighty":-1.815329,"marketCap":780847514},{"date":"2022-04-14","current":-6.092407,"twenty":-15.348585,"median":-4.910514,"eighty":-1.818793,"marketCap":766131202},{"date":"2022-04-22","current":-5.727284,"twenty":-15.348585,"median":-4.93957,"eighty":-1.836115,"marketCap":720216309},{"date":"2022-04-29","current":-5.877078,"twenty":-15.348585,"median":-4.99703,"eighty":-1.869901,"marketCap":739053188},{"date":"2022-05-06","current":-4.443703,"twenty":-15.348585,"median":-5.010782,"eighty":-1.905402,"marketCap":636704471},{"date":"2022-05-13","current":-4.144386,"twenty":-15.348585,"median":-5.010782,"eighty":-1.940046,"marketCap":593817642},{"date":"2022-05-20","current":-4.20718,"twenty":-15.348585,"median":-5.010782,"eighty":-1.992011,"marketCap":602814879},{"date":"2022-05-27","current":-4.148572,"twenty":-15.348585,"median":-5.010782,"eighty":-2.040855,"marketCap":594417457},{"date":"2022-06-03","current":-4.058568,"twenty":-15.348585,"median":-5.010782,"eighty":-2.078009,"marketCap":581521418},{"date":"2022-06-10","current":-3.767624,"twenty":-15.348585,"median":-5.010782,"eighty":-2.07862,"marketCap":539834220},{"date":"2022-06-17","current":-3.830418,"twenty":-15.348585,"median":-5.010782,"eighty":-2.107186,"marketCap":548831457},{"date":"2022-06-24","current":-4.112989,"twenty":-15.354462,"median":-5.011529,"eighty":-2.165229,"marketCap":589319023},{"date":"2022-07-01","current":-3.830418,"twenty":-15.354462,"median":-5.011529,"eighty":-2.251839,"marketCap":548831457},{"date":"2022-07-08","current":-3.958098,"twenty":-15.354462,"median":-5.011529,"eighty":-2.306182,"marketCap":567125838},{"date":"2022-07-15","current":-4.70325,"twenty":-15.354462,"median":-5.011529,"eighty":-2.355854,"marketCap":673893051},{"date":"2022-07-22","current":-4.962798,"twenty":-15.354462,"median":-5.02511,"eighty":-2.393877,"marketCap":711081630},{"date":"2022-07-29","current":-5.358398,"twenty":-15.354462,"median":-5.051511,"eighty":-2.514569,"marketCap":767764224},{"date":"2022-08-05","current":-5.479799,"twenty":-15.354462,"median":-5.071206,"eighty":-2.577332,"marketCap":785158882},{"date":"2022-08-12","current":-5.583625,"twenty":-15.354462,"median":-5.085412,"eighty":-2.618223,"marketCap":874761073},{"date":"2022-08-19","current":-5.566356,"twenty":-15.354462,"median":-5.130803,"eighty":-2.648853,"marketCap":872055627},{"date":"2022-08-26","current":-5.658457,"twenty":-15.354462,"median":-5.14291,"eighty":-2.717642,"marketCap":886484675},{"date":"2022-09-02","current":-5.702589,"twenty":-15.354462,"median":-5.161645,"eighty":-2.789962,"marketCap":893398594},{"date":"2022-09-09","current":-6.118962,"twenty":-15.354462,"median":-5.168988,"eighty":-2.83992,"marketCap":958629919},{"date":"2022-09-16","current":-6.537255,"twenty":-15.354462,"median":-5.170108,"eighty":-2.841532,"marketCap":1024161848},{"date":"2022-09-23","current":-6.120881,"twenty":-15.354462,"median":-5.21571,"eighty":-2.8635,"marketCap":958930524},{"date":"2022-09-30","current":-7.103292,"twenty":-15.354462,"median":-5.232811,"eighty":-2.877762,"marketCap":1112840376},{"date":"2022-10-07","current":-6.569874,"twenty":-15.354462,"median":-5.260185,"eighty":-2.877762,"marketCap":1029272136},{"date":"2022-10-14","current":-1.189638,"twenty":-15.354462,"median":-5.278901,"eighty":-2.870556,"marketCap":186375211},{"date":"2022-10-21","current":-1.345059,"twenty":-15.354462,"median":-5.278901,"eighty":-2.841532,"marketCap":210724231},{"date":"2022-10-28","current":-1.256795,"twenty":-15.354462,"median":-5.278901,"eighty":-2.841532,"marketCap":196896392},{"date":"2022-11-04","current":-1.220339,"twenty":-15.354462,"median":-5.278901,"eighty":-2.789962,"marketCap":191184894},{"date":"2022-11-11","current":-1.245325,"twenty":-15.354462,"median":-5.278901,"eighty":-2.717642,"marketCap":191129939},{"date":"2022-11-18","current":-1.164918,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":178789265},{"date":"2022-11-25","current":-1.029599,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":158020815},{"date":"2022-12-02","current":-0.902125,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":138456333},{"date":"2022-12-09","current":-0.525586,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":80665864},{"date":"2022-12-16","current":-0.660905,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":101434314},{"date":"2022-12-23","current":-0.590304,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":90598601},{"date":"2022-12-30","current":-0.684438,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":105046218},{"date":"2023-01-06","current":-0.645216,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":99026377},{"date":"2023-01-13","current":-0.80799,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":124008716},{"date":"2023-01-20","current":-0.933504,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":143272206},{"date":"2023-01-27","current":-0.80799,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":124008716},{"date":"2023-02-03","current":-0.80799,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":124008716},{"date":"2023-02-10","current":-0.733467,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":112571019},{"date":"2023-02-17","current":-0.719739,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":110464075},{"date":"2023-02-24","current":-0.651099,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":99929353},{"date":"2023-03-03","current":-0.698166,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":107153162},{"date":"2023-03-10","current":-0.56677,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":86986696},{"date":"2023-03-17","current":-0.484402,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":74345031},{"date":"2023-03-24","current":-0.435071,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":68325190},{"date":"2023-03-31","current":-0.433154,"twenty":-15.348585,"median":-5.270935,"eighty":-2.684884,"marketCap":68024198},{"date":"2023-04-06","current":-0.425488,"twenty":-15.348585,"median":-5.270935,"eighty":-2.684884,"marketCap":66820230},{"date":"2023-04-14","current":-0.490653,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":77053959},{"date":"2023-04-21","current":-0.511735,"twenty":-15.354462,"median":-5.278901,"eighty":-2.644504,"marketCap":80364872},{"date":"2023-04-28","current":-0.525152,"twenty":-15.354462,"median":-5.278901,"eighty":-2.598617,"marketCap":82471816},{"date":"2023-05-05","current":-0.58265,"twenty":-15.354462,"median":-5.278901,"eighty":-2.528919,"marketCap":91501577},{"date":"2023-05-12","current":-0.664355,"twenty":-15.354462,"median":-5.278901,"eighty":-2.410667,"marketCap":95414473},{"date":"2023-05-19","current":-0.651781,"twenty":-15.354462,"median":-5.278901,"eighty":-2.359402,"marketCap":93608521},{"date":"2023-05-26","current":-0.595195,"twenty":-15.354462,"median":-5.278901,"eighty":-2.316826,"marketCap":85481736},{"date":"2023-06-02","current":-0.570046,"twenty":-15.354462,"median":-5.278901,"eighty":-2.284445,"marketCap":81869832},{"date":"2023-06-09","current":-0.588908,"twenty":-15.354462,"median":-5.278901,"eighty":-2.165229,"marketCap":84578760},{"date":"2023-06-16","current":-0.534418,"twenty":-15.354462,"median":-5.278901,"eighty":-2.143555,"marketCap":76752967},{"date":"2023-06-23","current":-0.536514,"twenty":-15.360338,"median":-5.282659,"eighty":-2.165229,"marketCap":77053959},{"date":"2023-06-30","current":-0.521844,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":74947015},{"date":"2023-07-07","current":-0.52394,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":75248007},{"date":"2023-07-14","current":-0.591004,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":84879752},{"date":"2023-07-21","current":-0.62244,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":89394632},{"date":"2023-07-28","current":-0.519748,"twenty":-15.366215,"median":-5.286416,"eighty":-2.085105,"marketCap":74646023},{"date":"2023-08-04","current":-0.546993,"twenty":-15.366215,"median":-5.286416,"eighty":-2.022579,"marketCap":78558919},{"date":"2023-08-11","current":-0.66738,"twenty":-15.366215,"median":-5.286416,"eighty":-1.995475,"marketCap":86083720},{"date":"2023-08-18","current":-0.665046,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":85782728},{"date":"2023-08-25","current":-0.744385,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":96016457},{"date":"2023-09-01","current":-0.788722,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":101735306},{"date":"2023-09-08","current":-0.828391,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":106852170},{"date":"2023-09-15","current":-0.772387,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":99628361},{"date":"2023-09-22","current":-0.669713,"twenty":-15.366215,"median":-5.286416,"eighty":-1.912331,"marketCap":86384712},{"date":"2023-09-29","current":-0.686048,"twenty":-15.445182,"median":-5.286416,"eighty":-1.627406,"marketCap":88491656},{"date":"2023-10-06","current":-0.700049,"twenty":-15.518272,"median":-5.28644,"eighty":-1.900782,"marketCap":90297609},{"date":"2023-10-13","current":-0.746719,"twenty":-15.518272,"median":-5.28644,"eighty":-1.878374,"marketCap":96317449},{"date":"2023-10-20","current":-0.723384,"twenty":-15.518272,"median":-5.28644,"eighty":-1.444835,"marketCap":93307529},{"date":"2023-10-27","current":-0.732718,"twenty":-15.783249,"median":-5.288487,"eighty":-1.358874,"marketCap":94511497},{"date":"2023-11-03","current":-0.711716,"twenty":-15.783249,"median":-5.288487,"eighty":-1.26447,"marketCap":91802569},{"date":"2023-11-10","current":-0.806631,"twenty":-15.783249,"median":-5.288487,"eighty":-1.225327,"marketCap":89996616},{"date":"2023-11-17","current":-0.79584,"twenty":-15.783249,"median":-5.288487,"eighty":-1.187047,"marketCap":88792648},{"date":"2023-11-24","current":-0.782351,"twenty":-15.783249,"median":-5.288487,"eighty":-1.150072,"marketCap":87287688},{"date":"2023-11-30","current":-0.677139,"twenty":-15.828956,"median":-5.290509,"eighty":-1.129618,"marketCap":75548999},{"date":"2023-12-08","current":-0.690627,"twenty":-15.874664,"median":-5.294552,"eighty":-1.029599,"marketCap":77053959},{"date":"2023-12-15","current":-0.674441,"twenty":-15.920371,"median":-5.298596,"eighty":-0.904086,"marketCap":75248007},{"date":"2023-12-22","current":-0.79584,"twenty":-15.920371,"median":-5.298596,"eighty":-0.874579,"marketCap":88792648},{"date":"2023-12-29","current":-1.022452,"twenty":-15.966078,"median":-5.300095,"eighty":-0.866825,"marketCap":114075979},{"date":"2024-01-05","current":-0.834958,"twenty":-16.008223,"median":-5.301594,"eighty":-0.865648,"marketCap":93157033},{"date":"2024-01-12","current":-0.89296,"twenty":-16.008223,"median":-5.301594,"eighty":-0.865648,"marketCap":99628361},{"date":"2024-01-19","current":-0.919937,"twenty":-16.050367,"median":-5.303846,"eighty":-0.860157,"marketCap":102638282},{"date":"2024-01-26","current":-0.97659,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":108959114},{"date":"2024-02-02","current":-1.23018,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":137252365},{"date":"2024-02-09","current":-1.413628,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":157719823},{"date":"2024-02-16","current":-1.421721,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":158622799},{"date":"2024-02-23","current":-1.494561,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":166749584},{"date":"2024-03-01","current":-1.65238,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":184357618},{"date":"2024-03-08","current":-1.718475,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":191731923},{"date":"2024-03-15","current":-1.356975,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":151398991},{"date":"2024-03-22","current":-1.423315,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":140611781},{"date":"2024-03-28","current":-1.401935,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":138499587},{"date":"2024-04-05","current":-1.432478,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":141517007},{"date":"2024-04-12","current":-1.423315,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":140611781},{"date":"2024-04-19","current":-1.313359,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":129749068},{"date":"2024-04-26","current":-1.1301,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":111644547},{"date":"2024-05-03","current":-1.136209,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":112248031},{"date":"2024-05-10","current":-1.21595,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":114661967},{"date":"2024-05-17","current":-1.116754,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":105307964},{"date":"2024-05-24","current":-0.995159,"twenty":-15.966078,"median":-5.288487,"eighty":-0.860941,"marketCap":93841768},{"date":"2024-05-31","current":-0.95996,"twenty":-15.966078,"median":-5.288487,"eighty":-0.860941,"marketCap":90522606},{"date":"2024-06-07","current":-0.943961,"twenty":-15.966078,"median":-5.282683,"eighty":-0.860941,"marketCap":89013895},{"date":"2024-06-14","current":-0.96316,"twenty":-15.966078,"median":-5.258417,"eighty":-0.860941,"marketCap":90824348},{"date":"2024-06-21","current":-0.96956,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":91427832},{"date":"2024-06-28","current":-0.95996,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":90522606},{"date":"2024-07-05","current":-0.96636,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":91126090},{"date":"2024-07-12","current":-1.299146,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":122507260},{"date":"2024-07-19","current":-1.331145,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":125524680},{"date":"2024-07-26","current":-1.257548,"twenty":-16.008223,"median":-5.239474,"eighty":-0.860549,"marketCap":118584613},{"date":"2024-08-02","current":-1.151952,"twenty":-16.008223,"median":-5.232811,"eighty":-0.860549,"marketCap":108627127},{"date":"2024-08-09","current":-0.799884,"twenty":-16.008223,"median":-5.219754,"eighty":-0.854534,"marketCap":69400664},{"date":"2024-08-16","current":-0.869439,"twenty":-16.008223,"median":-5.204724,"eighty":-0.846337,"marketCap":75435505},{"date":"2024-08-23","current":-0.963338,"twenty":-16.008223,"median":-5.170108,"eighty":-0.846337,"marketCap":83582539},{"date":"2024-08-30","current":-0.973771,"twenty":-16.008223,"median":-5.149086,"eighty":-0.846337,"marketCap":84487765},{"date":"2024-09-06","current":-0.834661,"twenty":-16.008223,"median":-5.140911,"eighty":-0.842956,"marketCap":72418084},{"date":"2024-09-13","current":-1.074626,"twenty":-16.008223,"median":-5.104523,"eighty":-0.842956,"marketCap":93238284},{"date":"2024-09-20","current":-1.220692,"twenty":-16.008223,"median":-5.07622,"eighty":-0.842956,"marketCap":105911449},{"date":"2024-09-27","current":-1.172003,"twenty":-16.008223,"median":-5.056005,"eighty":-0.842956,"marketCap":101687060},{"date":"2024-10-04","current":-1.210259,"twenty":-16.008223,"median":-5.004447,"eighty":-0.842956,"marketCap":105006222},{"date":"2024-10-11","current":-1.151137,"twenty":-16.008223,"median":-4.962798,"eighty":-0.842956,"marketCap":99876608},{"date":"2024-10-18","current":-1.255469,"twenty":-16.008223,"median":-4.912471,"eighty":-0.842956,"marketCap":108928869},{"date":"2024-10-25","current":-1.258947,"twenty":-15.783249,"median":-4.85991,"eighty":-0.842956,"marketCap":109230611},{"date":"2024-11-01","current":-1.213736,"twenty":-15.402661,"median":-4.815435,"eighty":-0.842956,"marketCap":105307964},{"date":"2024-11-08","current":-1.144345,"twenty":-15.202709,"median":-4.785111,"eighty":-0.842956,"marketCap":98971382},{"date":"2024-11-15","current":-1.050146,"twenty":-14.670355,"median":-4.777025,"eighty":-0.842956,"marketCap":90824348},{"date":"2024-11-22","current":-0.97688,"twenty":-14.055521,"median":-4.73255,"eighty":-0.842956,"marketCap":84487765},{"date":"2024-11-29","current":-1.053635,"twenty":-13.770683,"median":-4.70325,"eighty":-0.842956,"marketCap":91126090},{"date":"2024-12-06","current":-0.159615,"twenty":-13.72108,"median":-4.649664,"eighty":-0.834899,"marketCap":13804697},{"date":"2024-12-13","current":-0.128041,"twenty":-13.506136,"median":-4.638411,"eighty":-0.827185,"marketCap":11073932},{"date":"2024-12-20","current":-0.126611,"twenty":-13.359584,"median":-4.586586,"eighty":-0.820859,"marketCap":10950217},{"date":"2024-12-27","current":-0.133623,"twenty":-13.288938,"median":-4.559388,"eighty":-0.809644,"marketCap":11556719},{"date":"2025-01-03","current":-0.164011,"twenty":-13.246851,"median":-4.534433,"eighty":-0.807718,"marketCap":14184892},{"date":"2025-01-10","current":-0.14388,"twenty":-13.18372,"median":-4.502605,"eighty":-0.799884,"marketCap":12443840},{"date":"2025-01-17","current":-0.130413,"twenty":-13.152155,"median":-4.426601,"eighty":-0.79584,"marketCap":11279116},{"date":"2025-01-24","current":-0.135786,"twenty":-13.119839,"median":-4.312651,"eighty":-0.79469,"marketCap":11743799},{"date":"2025-01-31","current":-0.121761,"twenty":-13.103304,"median":-4.191086,"eighty":-0.786174,"marketCap":10530796},{"date":"2025-02-07","current":-0.107841,"twenty":-12.950739,"median":-4.125642,"eighty":-0.776093,"marketCap":9326845},{"date":"2025-02-14","current":-0.116144,"twenty":-12.744814,"median":-4.0795,"eighty":-0.760749,"marketCap":10044991},{"date":"2025-02-21","current":-0.102921,"twenty":-12.680181,"median":-4.040776,"eighty":-0.74394,"marketCap":8901389},{"date":"2025-02-28","current":-0.09071,"twenty":-12.574212,"median":-3.996821,"eighty":-0.734417,"marketCap":7845292},{"date":"2025-03-07","current":-0.099956,"twenty":-12.358517,"median":-3.916236,"eighty":-0.728984,"marketCap":8644908},{"date":"2025-03-14","current":-0.102119,"twenty":-12.269833,"median":-3.868094,"eighty":-0.723384,"marketCap":8831988},{"date":"2025-03-21","current":-0.103375,"twenty":-11.885039,"median":-3.775996,"eighty":-0.718562,"marketCap":8940616},{"date":"2025-03-28","current":-0.123131,"twenty":-10.929494,"median":-3.547268,"eighty":-0.710316,"marketCap":9847954},{"date":"2025-04-04","current":-0.113047,"twenty":-10.655144,"median":-3.353412,"eighty":-0.698919,"marketCap":9041397},{"date":"2025-04-11","current":-0.122633,"twenty":-10.448396,"median":-3.001655,"eighty":-0.697715,"marketCap":9808124},{"date":"2025-04-17","current":-0.120268,"twenty":-10.281082,"median":-2.848446,"eighty":-0.693515,"marketCap":9618932},{"date":"2025-04-25","current":-0.267718,"twenty":-9.997718,"median":-2.646772,"eighty":-0.685082,"marketCap":21411915},{"date":"2025-05-02","current":-0.151517,"twenty":-9.811335,"median":-1.71308,"eighty":-0.677139,"marketCap":12118261},{"date":"2025-05-09","current":-0.174093,"twenty":-9.402585,"median":-1.607867,"eighty":-0.674441,"marketCap":13923885},{"date":"2025-05-16","current":-0.202103,"twenty":-9.002788,"median":-1.53233,"eighty":-0.670112,"marketCap":15301337},{"date":"2025-05-23","current":-0.269616,"twenty":-8.533644,"median":-1.494561,"eighty":-0.666194,"marketCap":20412847},{"date":"2025-05-30","current":-0.316394,"twenty":-8.208593,"median":-1.489165,"eighty":-0.664827,"marketCap":23954393},{"date":"2025-06-06","current":-0.359489,"twenty":-7.947417,"median":-1.470281,"eighty":-0.659728,"marketCap":27217130},{"date":"2025-06-13","current":-0.309599,"twenty":-7.862251,"median":-1.438587,"eighty":-0.651372,"marketCap":23439923},{"date":"2025-06-20","current":-0.306837,"twenty":-7.640819,"median":-1.423315,"eighty":-0.647899,"marketCap":23230816},{"date":"2025-06-27","current":-0.295088,"twenty":-7.572213,"median":-1.416945,"eighty":-0.644229,"marketCap":22341280},{"date":"2025-07-03","current":-0.276192,"twenty":-7.44683,"median":-1.393957,"eighty":-0.627565,"marketCap":20910721},{"date":"2025-07-11","current":-0.293772,"twenty":-7.295423,"median":-1.362735,"eighty":-0.62244,"marketCap":22241705},{"date":"2025-07-18","current":-0.260892,"twenty":-7.17619,"median":-1.349826,"eighty":-0.61587,"marketCap":19752334},{"date":"2025-07-25","current":-0.291624,"twenty":-7.068194,"median":-1.312652,"eighty":-0.600644,"marketCap":22079066},{"date":"2025-07-28","current":-0.283514,"twenty":-6.9959,"median":-1.307396,"eighty":-0.59771,"marketCap":21465021}],"updateTime":1753836958481}}}